CODX ▲ +2.1% - Co-Diagnostics, Inc. $CODX CODX - Co-Diagnostics to Participate in Joint WHO/Unitaid/UNAIDS Annual Consultation Meeting on September 17-18, 2026 Co-Diagnostics rose 2.1% today following news that the company will participate in a joint WHO/Unitaid/UNAIDS Annual Consultation Meeting scheduled for September 17-18, 2026. The participation suggests potential engagement with major global health organizations on diagnostics initiatives, which investors may view as a positive development for the company's profile and market opportunities in infectious disease testing. 17-SEP-2026 09:04 AM ET